Companies
Nuclear Threat Initiative | bio
advocates for mandatory screening of DNA-synthesis orders to close a biosecurity gap, publishes on managed-access controls to prevent AI tools from being used to design dangerous pathogens, and works to reduce state-level biological-weapons risks.
- Country
- United States
Research institute
Coverage
| CN | EU | US | |
|---|---|---|---|
| policy-institutions | ✓ | ✓ | ✓ |
Regulatorsfdaema
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Affiliation | NTI | bio is a program under the Nuclear Threat Initiative (NTI) based in Washington, DC | talents.vaia.com · causeiq.com · nti.org |
| Research focus | Reducing biological risks, biosecurity, DNA synthesis screening, AI-enabled biological risks, biosafety, and strengthening the Biological Weapons Convention | talents.vaia.com · causeiq.com · nti.org |
| Facility | International Biosecurity and Biosafety Initiative for Science (IBBIS) (incubated and launched by NTI) | causeiq.com · nti.org |
| Grant | Funding received from sources including the Bill & Melinda Gates Foundation, Carnegie Corporation of New York, Open Philanthropy, and Peter G. Peterson Foundation | causeiq.com · nti.org |
| Publications | Reports including 'Biosecurity Innovation and Risk Reduction: A Global Framework for Accessible, Safe and Secure DNA Synthesis' and 'Developing Guardrails for AI Biodesign Tools' | causeiq.com · nti.org |
| Principal staff | Jake Jordan (Vice President), Hayley Severance (Deputy Vice President), David Stiefel (Director), and Nathan A. Paxton (Senior Director) | causeiq.com · nti.org |
| Headcount | The Vice President of NTI | bio supervises a team of nine staff members medium confidence | talents.vaia.com |
Independent sources: causeiq.com · nti.org · talents.vaia.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biological emergency preparedness | policy-institutions | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.